Insider Shareholders with Direct Ownership of Kiromic Biopharma, Inc. (KRBP)
This section provides a comprehensive overview of the insiders with direct ownership of Kiromic Biopharma, Inc. (KRBP). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Kiromic Biopharma, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Internati Maurizio Chiriva
CHIEF EXECUTIVE OFFICER |
2,800 | 0 | 1,378,072 $1.93 Million | 1 |
Sep 09, 2021
Added 0.2%
|
|
Scott Dahlbeck
Chief of Staff |
67,240 | 0 | 496,757 $695,459 | 2 |
Aug 11, 2022
Added 9.14%
|
|
Pietro Bersani
Chief Executive Officer |
693,754 | 0 | 142,333 $199,266 | 6 |
Aug 26, 2024
Added 0.69%
|
|
Brian Hungerford
Chief Financial Officer |
64,933 | 0 | 64,933 $90,906 | 6 |
Aug 20, 2024
Added 5.45%
|
|
Daniel Grant Clark
Chief Financial Officer |
50,000 | 0 | 62,770 $87,878 | 1 |
Aug 11, 2022
Added 44.34%
|
|
Michael Charles Ryan
Officer |
50,189 | 0 | 50,189 $70,264 | 1 |
Jul 13, 2021
Added 50.0%
|
|
Michael Nagel
Director |
19,000 | 0 | 43,296 $60,614 | 2 |
Jun 11, 2024
Added 2.26%
|
|
Pamela Misajon
Director |
21,311 | 0 | 28,811 $40,335 | 3 |
Jun 12, 2024
Added 1.4%
|
|
Michael Catlin
Director |
18,000 | 0 | 25,500 $35,700 | 1 |
Mar 18, 2024
Added 41.38%
|
|
Jerry A. Schneider
Director |
5,000 | 0 | 5,000 $7,000 | 1 |
May 24, 2021
Added 50.0%
|